Showing results (451-460 of 489) with videos related to
Sort By:
Pageof 49
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.Journal of Ocular Biology, Diseases, and Informatics|September 14, 2010
Ocular disease in patients with ANCA-positive vasculitisAngela S Watkins, John H Kempen, Dongseok Choi, et al.The British Journal of Ophthalmology|October 26, 2013
Use of intravitreal rituximab for treatment of vitreoretinal lymphomaKelly L Larkin, Ujwala S Saboo, Grant M Comer, et al.Ophthalmic Epidemiology|February 27, 2008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyJohn H Kempen, Ebenezer Daniel, Sapna Gangaputra, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.Ophthalmology|April 24, 2017
Risk of Ocular Hypertension in Adults with Noninfectious UveitisEbenezer Daniel, Maxwell Pistilli, Srishti Kothari, et al.American Journal of Ophthalmology|April 6, 2019
Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive FactorsJohn H Kempen, Maxwell Pistilli, Hosne Begum, et al.American Journal of Ophthalmology|January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive FactorsJohn H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.Ocular Immunology and Inflammation|March 23, 2016
Adalimumab for Ocular InflammationKhayyam Durrani, John H Kempen, Gui-Shuang Ying, et al.Ophthalmology|December 22, 2015
Risk of Retinal Neovascularization in Cases of UveitisApurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.Pageof 49